Two-Year Outcomes in Children Born With a Congenital Pulmonary Malformation

Marie Blanquer1, Isabelle Monier2, Naziha Khen-Dunlop3

  • 1AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et Allergologie Pédiatriques, Paris, France.

Pediatrics
|May 5, 2026
PubMed

Insights

Only 15% of children with congenital pulmonary malformations (CPMs) developed symptoms requiring surgery. A larger CPM Volume Ratio (CVRmax) over 1 cm2 was a key risk factor for symptomatic progression in these pediatric cases.

Area of Science:

  • Pediatric Surgery
  • Pulmonology
  • Medical Imaging

Background:

  • Congenital pulmonary malformations (CPMs) present a diagnostic and management challenge for pediatric patients.
  • Shared decision-making between families and clinicians requires comprehensive data on CPM complications, especially for asymptomatic children.
  • Understanding symptom development is crucial for guiding surgical interventions in pediatric CPM cases.

Purpose of the Study:

  • To prospectively document the occurrence of symptoms in children diagnosed with congenital pulmonary malformations (CPMs).
  • To identify specific markers or indicators associated with the need for surgical intervention due to symptomatic progression in pediatric CPM.
  • To inform clinical practice and family counseling regarding the management of asymptomatic congenital pulmonary malformations.

Main Methods:

  • A prospective, population-based, nationally representative cohort (MALFPULM) was established, including pregnant women with fetuses diagnosed with CPM.
  • Follow-up data were collected from birth to 2 years of age.
  • Outcomes were compared among children who did not undergo surgery, those who had elective surgery, and those operated on due to symptoms.

Main Results:

  • Of 322 children with follow-up, 15% (48) required surgery for symptoms.
  • Children operated on for symptoms exhibited higher prenatal maximal CPM Volume Ratio (CVRmax), neonatal respiratory distress, eating difficulties, pneumothorax, and respiratory hospitalizations compared to elective surgery cases.
  • A CVRmax greater than 1 cm2 was significantly associated with symptomatic surgical intervention (44% vs. 14%).
  • CPM infection occurred in only 3% of cases, with no significant link to the malformation's cystic nature.
  • Symptom frequency did not significantly differ between non-operated and elective surgery groups, with cough and wheezing being most common.

Conclusions:

  • Symptomatic progression necessitating surgery occurred in a minority (15%) of children with CPM.
  • Prenatal CVRmax exceeding 1 cm2 is a significant risk factor for developing symptoms requiring surgical intervention in pediatric CPM.
  • Elective surgery did not appear to alter the incidence of less severe symptoms in children with CPM.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.7K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K